ABSTRACT The effects of two topical nasal preparations on human nasal ciliary beat frequency in vitro and on nasal mucociliary clearance in vivo were investigated. Betamethasone and betamethasone with neomycin drops were found to be ciliotoxic when ciliated epithelium was exposed to them in vitro, mainly owing to the effects of the preservatives benzalkonium chloride and thiomersal. The nasal mucociliary clearance and in vitro ciliary beat frequency of nasal ciliated epithelium taken from healthy subjects were not adversely affected after topical application; neither did treatment with betamethasone, with or without neomycin, for four weeks affect these indices in two groups of patients with rhinitis. Thus, despite a ciliotoxic effect when ciliated epithelium is exposed to these preparations in vitro, they do not affect nasal clearance or ciliary beat frequency (as measured in vitro) adversely when administered topically to the nose.
Mucociliary clearance is a major element of the defence system of the whole respiratory tract, potentially noxious substances trapped in the mucus blanket being removed by the coordinated beat of the cilia. Reduction of mucociliary clearance, whether primary or secondary, may allow potentially harmful material such as microorganisms or allergens to remain in contact with the epithelium, causing or exacerbating existing disease. Severely disordered mucociliary clearance in patients with primary ciliary dyskinesia leads to chronic infections of both the upper and the lower respiratory tracts.
Various preservatives in topical medications were shown by van de Donk and coworkers to be ciliotoxic to animal cilia in vitro.' They reported a similar toxic effect on human adenoidal cilia2 and also a slowing of nasal mucociliary clearance after administration of benzalkonium chloride with ethylenediamine-tetra-acetic acid (EDTA).3 Nasal mucociliary clearance is prolonged in rhinitis4 and further impairment due to therapy would be undesirable.
This study examined the effects of betamethasone Accepted 19 March 1985 nose drops (Betnesol, Glaxo) and betamethasone with neomycin drops (Betnesol-N, Glaxo) on human nasal cilia in vitro and on nasal mucociliary clearance after acute and long term use. The following substances were tested at varying concentrations: betamethasone nose drops and betamethasone with neomycin nose drops reconstituted from pure ingredients, and the individual constituents betamethasone, neomycin, benzalkonium chloride, EDTA, and thiomersal. The betamethasone nose drops contained betamethasone sodium phosphate 1.0 mg/ml; benzalkonium chloride 200 ag/ml; EDTA 100 ,ug/ml. The betamethasone with neomycin nose drops contained betamethasone sodium phosphate 1.0 mg/ml; neomycin 5.0 mg/ml; thiomersal 50 ,ug/ml.
Methods
Cilia from each of the five subjects were examined at each drug concentration and time point, and the overall ciliary beat frequency results calculated as a mean of these five experiments. All drug solutions were verified to have a pH of 6.8-7.2.
To investigate the reversibility of any toxic effect, cilia exposed to betamethasone and to betamethasone with neomycin drops were resuspended in fresh medium 199 after gentle centrifugation (186 g for 10 minutes). In addition, an experiment using benzalkonium chloride with EDTA was performed at 25°C so that any effect of temperature on results could be demonstrated. The action of the chelating agent EDTA was further investigated by using Dulbecco A phosphate buffered saline (Oxoid Ltd), which is free of calcium and magnesium, in place of medium 199.
IN VIVO EXPERIMENTS
Acute effect ofbetamethasone drops on nasal mucociliary clearance and ciliary beat frequency The subjects were six healthy volunteers with no history of chronic respiratory disease and no recent acute upper respiratory infection. Nasal mucociliary clearance was measured in one nostril by a saccharin technique6 as modified by Rutland Long term effects ofbetamethasone and betamethasone with neomycin drops on nasal mucociliary clearance Nasal mucociliary clearance was measured by the saccharin technique as before in two groups of patients before and after treatment with two drops instilled in each nostril twice daily for one month. The betamethasone treated group consisted of 36 patients with perennial non-allergic rhinitis (longer than 12 months' history of watery rhinorrhoea, nasal obstruction, and sneezing with no history of allergy, negative skinprick test responses to common allergens, and normal serum IgE). The group treated with betamethasone with neomycin consisted of 40 patients suffering from chronic rhinosinusitis with infection (longer than six months' history of mucopurulent rhinorrhoea or postnasal discharge and abnormal sinus radiographs).
No patient was having any topical nasal treatment when initially tested and nasal mucociliary clearance was measured in the same nostril before and after treatment. The last dose of drops was six to eight hours before the second clearance measurement. Clinical response to treatment was also documented.
Results

IN VITRO EXPERIMENTS
The results observed with betamethasone and betamethasone with neomycin drops at the concentration found in the commercial preparations and with dilutions to 1:50 are shown in figures 1 and 2.
Betamethasone drops in a dilution of 1:2 caused ciliostasis within five minutes and 1:10 caused ciliostasis in 90 minutes. At 1:25 dilution the mean ciliary beat frequency after 360 minutes was 68% (9.1%) of control (medium 199 alone) values. No difference from control was seen at a dilution of 1:50. Betamethasone with neomycin drops caused ciliostasis within five minutes in a dilution of 1: 2, but after 180 and 360 minutes at 1: 10 and 1:25 respectively. There was no difference from control time at 1:50 dilution. After ciliostasis had occurred it was observed that there was considerable distortion of cellular architecture and there was no reversal of the effect after resuspension of the epithelium in fresh medium 199.
When the individual constituents of the drops were used, betamethasone and EDTA had no significant effect on cilia at concentrations of up to 4 mg/ml and 1 mg/ml respectively-that is, at considerably higher concentrations than are found in the 
TIME (minutes)
of ciliary beat frequency than did 20 ug/ml benzalkonium chloride alone, but complete ciliostasis occurred only after 120 minutes compared with 60 minutes without EDTA (fig 3) . Benzalkonium chloride 60 ug/ml with EDTA 1 mg/ml caused a reduction in ciliary beat frequency to 50% (28.4%) of the control value after five minutes and complete ciliostasis after 10 minutes. At 25°C, however, the reduction in ciliary beat frequency was less, being 79% (15.0%) of control after five minutes and 53% (7.0%) after 30 (10.9) min).
Discussion
The nasal mucous membranes have an area of 160 cm2 approximately,9 the maximum depth of the mucus layer above the tips of the cilia is about 20
Am,"0 and around the cilia the periciliary fluid has a depth of about 5 ,m. On the basis of these figures the volume of secretion in the normal nose can be calculated to be about 0.4 ml. The recommended dose for both commercial preparations is two to three drops (about 0.13-0.20 ml) in each nostril (Glaxo data sheet). Both preparations were ciliotoxic in vitro at a dilution of 1: 2, which might be expected in the nose immediately after use. In the case of the betamethasone drops the ciliotoxicity was due to the preservative benzalkonium chloride, whereas in the betamethasone with neomycin drops the toxicity was mainly due to the preservative thiomersal with a small contribution from the neomycin. Dilution of the drops in excess of 1:25 was required to abrogate these effects.
We found ciliostasis within five minutes with benzalkonium chloride 100 ,ug/ml and thiomersal 50
,g/ml. Van chick embryo tracheal cilia and an additive toxic effect when EDTA was combined with benzalkonium chloride. This effect was probably due to chelation of extracellular calcium. The lack of toxicity of EDTA alone and the lack of enhancement of the toxicity of benzalkonium chloride by EDTA in our human system, even in the presence of calcium free medium, presumably reflects a species difference. These results emphasise that when drug effects on human cilia are investigated cilia from the same species'3 should be used, at physiological temperature.
Despite the in vitro ciliotoxicity of these preparations we did not observe any significant effect on nasal mucociliary clearance in either the acute or the long term study, or any effect on nasal ciliary beat frequency before and after treatment. This may have been due to dilutional effects of nasal mucus, protection of the cilia by the mucus blanket, or a higher resistance of the cilia in situ. In vitro studies use a relatively mucus depleted preparation of isolated epithelial strips. In a study by Van de Donk et a13 nasal mucociliary clearance (measured by a saccharin and dye method) was prolonged 15 minutes after administration of one drop of a solution containing benzalkonium chloride 60 ,ug/ml with EDTA 1 mg/ml. In their study, however, the subjects rinsed their noses with saline 15 minutes before the initial clearance was measured and 15 minutes before the treatment; thus the nasal mucus could have been diluted or disrupted or both. In our study nasal mucociliary clearance did show a tendency (which failed to reach significance) to quicken in the patients with perennial rhinitis who improved clinically after treatment with betamethasone drops, but it did not change in the patients with chronic sinusitis who improved clinically. This may be due to pathological differences between these conditions rather than any different effect of betamethasone with neomycin drops in the latter group.
In conclusion, betamethasone and betamethasone with neomycin drops are ciliotoxic when ciliated epithelium is exposed to them in vitro, owing to the preservatives benzalkonium chloride and thiomersal. We have, however, found no evidence of in vivo mucociliary dysfunction after acute or long term administration. 
